Comments
Sun Pharmaceutical Industries Ltd gained 2 per cent in the morning session on Wednesday, after falling 8.8 per cent on Tuesday.
JP Morgan said it will use the weakness post Daiichi's share sale as a buying opportunity.
Japan's Daiichi Sankyo Co Ltd raised $3.2 billion from the Sun Pharma stake sale.
Goldman Sachs, the Government of Singapore and Aranda Investment Mauritius, a subsidiary of Temasek Holdings, were among the top buyers, according to exchange data.
Sun Pharma said founder Dilip Shanghvi has not bought shares in the Daiichi Sankyo deal.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.